Actively Recruiting

Age: 18Years - 75Years
All Genders
ID07021742

BioHealx Anal Fistula Device Post Market Surveillance Study Assessing Long-Term Durability and Effectiveness for Fistula-in-Ano Closure

Led by Signum Surgical USA Inc. · Updated on 2026-06-03

50

Participants Needed

6

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the long-term durability and effectiveness of the BioHealx Anal Fistula Device in closing fistula-in-ano, which involves both internal and external fistula openings. This post market surveillance study is a single-arm, multicenter trial designed to observe outcomes after treatment with this device. Participants will have their anal fistula treated with the BioHealx device, a bioabsorbable implant that securely closes the internal fistula opening to prevent reinfection while allowing drainage through the external opening during healing. The study monitors participants over time to assess fistula closure and recurrence rates. During the study, participants will be followed up regularly for up to 36 months. Researchers will measure successful closure repair at 12 months and track non-recurrence incidence at 24 and 36 months. Secondary outcomes include assessments of fecal incontinence quality of life, severity index scores, general health-related quality of life, pain scores, and use of analgesics and antibiotics. Participants will have ongoing evaluations and follow-up contacts to monitor these outcomes.

CONDITIONS

Brief Title

BioHealx® Anal Fistula Device Post Market Surveillance Study

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 - 75 years
  • Presence of single continuous anal fistula presenting for initial curative surgery
  • Failed or recurrent anal fistula closure
  • Minimum of 6 weeks of draining seton placed prior to procedure
  • Availability for follow-up contacts and willingness to complete informed consent
Not Eligible

You will not qualify if you...

  • Fistula tract shorter than 2 cm
  • Complex fistula tract (branching)
  • Body mass index over 35
  • Known uncontrolled diabetes or other systemic condition impairing healing
  • Known HIV-positive or immunocompromised status
  • Rectal prolapse
  • Pregnancy
  • Rectal or fistula malignancy
  • Crohn's disease
  • Ulcerative proctitis
  • Hidradenitis suppurativa of the anal region
  • Pilonidal sinus disease
  • Presence of hemorrhoid involving fistula site
  • Continuous use of anti-inflammatory medication
  • Intersphincteric fistula in ano or fistula treatable by simple fistulotomy
  • Active infection or abscess involving fistula site
  • Known allergy to PLGA material
  • Any severe acute or uncontrolled chronic disease making patient unsuitable
  • Treatment with investigational drug or medical device in past 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Single procedure

Participants have their anal fistula treated with the BioHealx Anal Fistula Device, a bioabsorbable implant designed to securely close the fistula internal opening while allowing drainage during healing.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 36 months

Participants are followed to assess the long-term durability and effectiveness of the device in fistula closure and quality of life outcomes.

Multiple follow-up visits over 36 months

Trial Site Locations

Total: 6 locations

1

The Colorectal Institute

Fort Myers, Florida, United States, 33912

Actively Recruiting

2

Hackensack University Medical Center

Hackensack, New Jersey, United States, 07601

Actively Recruiting

3

Weill Cornell Medicine

New York, New York, United States, 10021

Actively Recruiting

4

Northwell Health

Staten Island, New York, United States, 10305

Actively Recruiting

5

Maininle Health Lankenau

Bryn Mawr, Pennsylvania, United States, 19010

Actively Recruiting

6

Geisinger

Danville, Pennsylvania, United States, 17822

Actively Recruiting

Loading map...

Research Team

K

Katy Feeny

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Collagen Paste Injection Compared With Mucosal Advancement F...

Fistula-in-ano

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here